Study details
Enrolling now
Transdermal Estrogen in Women With Anorexia Nervosa
Pouneh K. Fazeli, MD
NCT IDNCT03875378ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
66
Study length
about 8.3 years
Ages
19–45
Sex
Female only
Locations
1 site in PA
About this study
Researchers are testing whether transdermal estrogen can help improve bone health in women with anorexia nervosa. The trial will compare a treatment of transdermal estrogen to a placebo over 30 months.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebos
- 2.Take Transdermal estrogen
PhasePhase 2
DrugTransdermal estrogen
Routetransdermal
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Estrogen Receptor Agonists)
Drug routes
transdermal
Body systems
Psychiatry / Mental Health